Health News

Ebola could drain billions of dollars from African economies: World Bank

Photo

WASHINGTON - The largest-ever outbreak of Ebola could drain billions of dollars from economies in West Africa by the end of next year if the epidemic is not contained, the World Bank said in an analysis on Wednesday.

U.S. needs better end-of-life care, which might cut costs: study

WASHINGTON - The United States needs to improve its medical care for people nearing death, a move that might cut rising healthcare costs, an Institute of Medicine (IOM) study said on Wednesday.

U.S. 1:05pm EDT

French worker for medical charity MSF contracts Ebola in Liberia

PARIS - A French volunteer working for Medecins Sans Frontieres in Liberia has contracted the Ebola virus, the medical charity said in a statement on Wednesday.

2:22pm EDT

First UK volunteer gets experimental GSK Ebola shot in trial

LONDON - The first volunteer in a fast-tracked British safety trial of an experimental Ebola vaccine made by GlaxoSmithKline received the injection on Wednesday, trial organizers said.

1:18pm EDT

Salt and smoking may interact to raise rheumatoid arthritis risk

NEW YORK (Reuters Health) - Eating a diet high in salt may increase the risk of rheumatoid arthritis among smokers, according to a large study from Sweden.

2:34pm EDT

Study asks whether artificial sweeteners may drive diabetes

LONDON, Sept 17 - Scientists studying the effects of artificial sweeteners in mice and humans say they have found that eating them may increase the risk of developing glucose intolerance, a risk factor for diabetes.

1:17pm EDT

Officials warn of potentially toxic algae on major Portland river

PORTLAND Ore. - Public health officials in Oregon warned recreational boaters and swimmers who on warm days flock to a river that bisects Portland to stay out of the water on Wednesday after detecting what they suspect is a potentially dangerous toxic algae.

3:45pm EDT

Merck licenses experimental psoriasis drug to India's Sun Pharma

- Merck & Co Inc said it had licensed its experimental psoriasis drug to Indian generic maker Sun Pharmaceutical Industries Ltd for $80 million.

12:21pm EDT

For Roche CEO, celebrating failure is key to success

LONDON - Roche Chief Executive Severin Schwan likes to crack open the champagne with his drug research teams at the end of a big project - especially when they fail.

8:12am EDT

Study shows downward trend in Sovaldi utilization

- Over the last several months there has been a 'plateau and downward trend' in the use of Gilead Sciences Inc's controversial $1,000-a-pill hepatitis C treatment, Sovaldi, a CVS Health Corp analysis showed.

8:41am EDT